3 research outputs found
Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings
Stromal prostate tumors are rare neoplastic proliferative lesions that have been classified into prostatic
stromal tumor of uncertain malignant potential (STUMP) and prostatic stromal sarcoma (SS) based
on these criteria: stromal cellularity, presence of mitotic figures, necrosis, and stromal overgrowth. A
prostatic stromal tumor of uncertain malignant potential (STUMP) is a non-epithelial, mesenchymal
spindle-cell tumor that can be classified as a specialized stromal tumor of the prostate. STUMPs have
the capability to diffusely infiltrate the prostate gland and extend into adjacent tissues. Furthermore,
they often recur and this is why they are considered as neoplastic entities. STUMPs usually tend to be
not aggressive, but occasional cases have been reported with an extension into adjacent tissues. A
few cases develop a sarcomatous dedifferentiation.
A 67-year-old male referred to the Department of Urology, Sapienza Rome University, with acute urinary
retention (AUR) and bladder overdistention. Digital rectal examination (DRE) showed the presence
of a severe prostatic hyperplasia and a transvesical prostatic adenomectomy (TVPA) was performed.
The pathological evaluation performed at the Department of Pathology, Sapienza Rome University,
revealed an incidental diagnosis of prostatic STUMP. The patient’s follow-up is made every year with
transrectal ultrasonography and nuclear magnetic resonance with spectroscopy, and every two years
with a transperineal prostate biopsy to exclude a progression to a stromal sarcoma. After 5 years of
follow-up the STUMP is still detectable but there is no sign of sarcoma. As a result of its relative rarity
and lack of long-term follow-up, the prognosis of STUMP is unclear. Therapy varies from a wait-andsee
approach to a radical retropubic prostatectomy
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review
Nested variant of urothelial cell carcinoma (NVUC) is a rare histological entity, with about 80 reported cases. It has a deceptively benign appearance with an aspect characterized by confluent small nest or urothelial’s cell tubules. This tumour often resembles inverted papilloma, von Brunn’s nests (VBNs), cystitis cystica, nephrogenic metaplasia and sometimes usual transitional cell cancer. It is very important to be able to distinguish between benign lesions and nested variant bladder cancer because, in spite of its bland morphology, there is evidence that it behaves aggressively
Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings.
Stromal prostate tumors are rare neoplastic proliferative lesions that have been classified into prostatic stromal tumor of uncertain malignant potential (STUMP) and prostatic stromal sarcoma (SS) based on these criteria: stromal cellularity, presence of mitotic figures, necrosis, and stromal overgrowth. A prostatic stromal tumor of uncertain malignant potential (STUMP) is a non-epithelial, mesenchymal spindle-cell tumor that can be classified as a specialized stromal tumor of the prostate. STUMPs have the capability to diffusely infiltrate the prostate gland and extend into adjacent tissues. Furthermore, they often recur and this is why they are considered as neoplastic entities. STUMPs usually tend to be not aggressive, but occasional cases have been reported with an extension into adjacent tissues. A few cases develop a sarcomatous dedifferentiation. A 67-year-old male referred to the Department of Urology, Sapienza Rome University, with acute urinary retention (AUR) and bladder overdistention. Digital rectal examination (DRE) showed the presence of a severe prostatic hyperplasia and a transvesical prostatic adenomectomy (TVPA) was performed. The pathological evaluation performed at the Department of Pathology, Sapienza Rome University, revealed an incidental diagnosis of prostatic STUMP. The patient's follow-up is made every year with transrectal ultrasonography and nuclear magnetic resonance with spectroscopy, and every two years with a transperineal prostate biopsy to exclude a progression to a stromal sarcoma. After 5 years of follow-up the STUMP is still detectable but there is no sign of sarcoma. As a result of its relative rarity and lack of long-term follow-up, the prognosis of STUMP is unclear. Therapy varies from a wait-and-see approach to a radical retropubic prostatectomy